Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for BPMUF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2002. Start Trial.
Date Value
December 31, 2025 74.76M
December 31, 2024 84.44M
December 31, 2023 15.85M
December 31, 2022 7.388M
December 31, 2021 -35.02M
December 31, 2020 -57.67M
December 31, 2019 -64.24M
December 31, 2018 -80.94M
December 31, 2017 19.32M
December 31, 2016 -76.13M
December 31, 2015 -70.39M
December 31, 2014 -78.06M
Date Value
December 31, 2013 -64.15M
December 31, 2012 157.94M
December 31, 2011 -92.92M
December 31, 2010 102.32M
December 31, 2009 -105.48M
December 31, 2008 -117.45M
December 31, 2007 -65.82M
December 31, 2006 -57.83M
December 31, 2005 27.58M
December 31, 2004 -51.67M
December 31, 2003 -38.98M
December 31, 2002 -41.18M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Santhera Pharmaceuticals Holding AG -41.86M
BeOne Medicines Ltd. 1.131B
AC Immune SA -83.40M
CRISPR Therapeutics AG -345.01M
Idorsia Ltd. -203.32M